Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

NCT05929495 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma, IDH-wildtype
Metformin
Malignancies

Interventions

DRUG: Metformin

Sponsor

University of Milano Bicocca